Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Feigenbaum

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The International Journal of Neuroscience|January 1, 1983
Morphine may not produce true catalepsyJ J Feigenbaum, J Yanai, B H Moon, et al.
Pain|October 1, 1991
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking propertiesR Zeltser, Z Seltzer, A Eisen, et al.
Pharmacology, Biochemistry, and Behavior|February 1, 1982
The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypyJ J Feigenbaum, J Yanai, R B Blass, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 2. Characterization of the quantum yield of singlet oxygen generated by irradiation of dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Neurochemical Research|February 1, 1997
On the synthesis of neurotransmitter receptor agonists with antagonist potentialD S Crumrine, M D Choubal, J R Kanofsky, et al.
European Journal of Pharmacology|January 11, 1980
The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behaviorB H Moon, J J Feigenbaum, P E Carson, et al.
Psychopharmacology|January 1, 1982
Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the ratJ J Feigenbaum, B H Moon, R Catterton, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, K Payza, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates. 3. Comparative binding of dye-neuropeptide conjugates to FMRFamide receptors of Helix aspersa and Loligo pealeiJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blockerJ J Feigenbaum, F Bergmann, S A Richmond, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The International Journal of Neuroscience|January 1, 1983
Morphine may not produce true catalepsyJ J Feigenbaum, J Yanai, B H Moon, et al.
Pain|October 1, 1991
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking propertiesR Zeltser, Z Seltzer, A Eisen, et al.
Pharmacology, Biochemistry, and Behavior|February 1, 1982
The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypyJ J Feigenbaum, J Yanai, R B Blass, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 2. Characterization of the quantum yield of singlet oxygen generated by irradiation of dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Neurochemical Research|February 1, 1997
On the synthesis of neurotransmitter receptor agonists with antagonist potentialD S Crumrine, M D Choubal, J R Kanofsky, et al.
European Journal of Pharmacology|January 11, 1980
The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behaviorB H Moon, J J Feigenbaum, P E Carson, et al.
Psychopharmacology|January 1, 1982
Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the ratJ J Feigenbaum, B H Moon, R Catterton, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, K Payza, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates. 3. Comparative binding of dye-neuropeptide conjugates to FMRFamide receptors of Helix aspersa and Loligo pealeiJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blockerJ J Feigenbaum, F Bergmann, S A Richmond, et al.
Pageof 5